Pharmaceuticals
6 Top Biopharmaceutical Stock Picks You Should Know About
The aging population is creating a massive tailwind for companies that provide cutting-edge health care.
Arrowhead Pharmaceuticals Is Flying Higher on the Charts
Before I give my recommendation I want to visit with the charts and indicators.
The Long Decline in AbbVie Is Over
In addition to the yield let's check out the charts of ABBV.
It's as Simple as A-B-C, AmerisourceBergen Has Begun a New Leg Higher
Here's how to play the stock now.
McKesson Is Poised to Make a Significant Upside Breakout
Traders need to respect this price strength.
Jim Cramer: The Democrats Debate, and the Future of Corporations
I thought last night's debate was pretty frightening when it comes to managed care, banking, airlines, and drugs.
An Interesting Dividend Earner Just Cropped Up
Ingredion recently inched up its new quarterly dividend, and while the nation's corn production woes may cause a headwind for the company, its ample cash offers security.
Rite Aid Charts Send Wrong Signals to Investors Who Hope for a Recovery
Sellers of the drugstore chain's stock have been aggressive for months and the overall technical picture is weak.
With Trust Levels Low, It's Best to Tread Slowly
There is no upside leadership at present, although a few defensive groups such as pharmaceuticals are seeing some interest.
3 Biotech Plays That Would Work as Covered Calls
The SPDR S&P Biotech ETF, Alexion Pharmaceuticals and BioMarin Pharmaceuticals set up nicely for this options strategy.